The Use of Autologous Platelet Gel to Treat Difficult-to-Heal Wounds: A Pilot Study
Background:Chronic ulcers can benefit from topical treatment with growth factors (GFs). PLT gel provides tissue regeneration-inducing GFs. The aim of this study […]
Use of Autologous Fibrin-Platelet Glue and Bone Fragments in Maxillofacial Surgery
Abstract:The use of autologous cryo-platelet gel and bone fragments in maxillofacial surgery is described. Cryo-platelet gel has been used successfully in 5 […]
Effect of Platelet Concentration in Platelet-Rich Plasma on Peri-Implant Bone Regeneration
This study analyzed the effect of the platelet count in platelet-rich plasma (PRP) on bone regeneration in vivo. Twenty male New Zealand […]
Utilizing Autologous Growth Factors for Dental Surgery to Enhance Bone and Soft Tissue Grafts
Abstract: The addition to a graft site of an easily obtained autologous concentrate of blood platelets, called platelet rich plasma (PRP), offers […]
Histological Evaluation of Sinus Augmentation Using Platelet Rich Plasma (PRP)
Abstract:The use of Platelet Rich Plasma (PRP) in conjunction with autogenous bone graft materials has recently been advocated for use in sinus […]
Platelet-Rich Plasma Gel Promotes Differentiation and Regeneration During Equine Wound Healing
Nonhealing wounds of the lower equine limb represent a challenging model. The platelet is a natural source of a myriad of growth […]
Autologous Concentrated Platelet-Rich Plasma (cPRP) for Local Application in Bone Regeneration
Platelets are rich in growth factors that may contribute to an accelerated tissue regeneration process. The therapeutic osteogenic effect of local platelet […]
ADA: Autologous Platelet Gel Effectively Treats Diabetic Plantar Wounds
Use of the autologous platelet gel, AuTolo-Gel, to treat non-healing diabetic plantar surface wounds provides good volume reduction and wound healing, researchers […]
Cytomedix, Inc. Receives Favorable Patent Ruling In U.S. District Court
LITTLE ROCK, Ark., March 26, 2004 (PRIMEZONE) — Cytomedix, Inc. (CYME:OTC.OB) today announced it has received a favorable ruling from United States […]